Cargando…
Generation of New Isogenic Models of Huntington’s Disease Using CRISPR-Cas9 Technology
Huntington’s disease (HD) is a fatal neurodegenerative disorder caused by the expansion of CAG repeats in exon 1 of the huntingtin gene (HTT). Despite its monogenic nature, HD pathogenesis is still not fully understood, and no effective therapy is available to patients. The development of new techni...
Autores principales: | Dabrowska, Magdalena, Ciolak, Agata, Kozlowska, Emilia, Fiszer, Agnieszka, Olejniczak, Marta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7084361/ https://www.ncbi.nlm.nih.gov/pubmed/32182692 http://dx.doi.org/10.3390/ijms21051854 |
Ejemplares similares
-
Artificial miRNAs targeting CAG repeat expansion in ORFs cause rapid deadenylation and translation inhibition of mutant transcripts
por: Ciesiolka, Adam, et al.
Publicado: (2020) -
What, When and How to Measure—Peripheral Biomarkers in Therapy of Huntington’s Disease
por: Przybyl, Lukasz, et al.
Publicado: (2021) -
Efficient generation of isogenic primary human myeloid cells using CRISPR-Cas9 ribonucleoproteins
por: Hiatt, Joseph, et al.
Publicado: (2021) -
40008 COMBINED CRISPR/CAS9 AND AAV FOR THE GENERATION OF CONDITIONAL ISOGENIC GENE KNOCK-INS
por: Boddu, Prajwal, et al.
Publicado: (2021) -
qEva-CRISPR: a method for quantitative evaluation of CRISPR/Cas-mediated genome editing in target and off-target sites
por: Dabrowska, Magdalena, et al.
Publicado: (2018)